FDA throws Ranbaxy a manufacturing lifeline
October 15, 2013Manufacturing and Production FDA, Ranbaxy, recall
Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …
Boehringer submits NSCLC pill
October 14, 2013Sales and Marketing
Boehringer Ingelheim has submitted its oral triple angiokinase inhibitor nintedanib for scrutiny by the European Medicines Agency. Nintedanib was impressive …
Trials and tribulations
October 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, eric low, myeloma, transparency
I have been chief executive of Myeloma UK since its inception 17 years ago, and its unique bedside to bench …
inVentiv Health creates two senior appointments


October 14, 2013Medical Communications, Research and Development, Sales and Marketing inVentiv Health
The comms division of inVentiv Health has appointed two 
social media veterans to expand its digital footprint. Emma D’Arcy joins …
Janssen agrees Zytiga deal
October 14, 2013Sales and Marketing AstraZeneca, Janssen, Zytiga
Janssen has agreed to co-promote its once-daily prostate cancer pill Zytiga with AstraZeneca in Japan for an undisclosed sum. A …
Vetter swells filling capacity with $100m investment
October 11, 2013Manufacturing and Production API, Vetter, sterile liquid
German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over $100 million across its production …
Mixed tale for Pfizer psoriasis drug
October 11, 2013Sales and Marketing Enbrel, Pfizer, psoriasis, tofacitinib
Pfizer has seen its novel, oral Janus kinase (JAK) inhibitor tofacitinib turn in a mixed showing in late-stage trials in …
US shutdown affecting medical science
October 11, 2013Research and Development, Sales and Marketing FDA, Obama, Obamacare, us shutdown
American scientists and the latest Nobel Prize winners have condemned the US shutdown this week saying it is putting scientific …
Teva to axe 5,000 jobs in savings drive
October 11, 2013Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, Teva, cuts
The world’s largest generic drugmaker Teva will cut around 5,000 jobs from its global workforce as it looks to speed-up …
Alzheimer’s research ‘turning point’
October 11, 2013Research and Development, Sales and Marketing Alzheimer's, Alzheimer’s, MRC, research
There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …
Glide Pharma confirms Board changes and chairman
October 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Glide Pharma, morton
Pharma development and device firm Glide Pharma has appointed EUSA Pharma’s founder Bryan Morton as a non-executive chairman. The company …
PAN hires new associate director and head of Art
October 10, 2013Medical Communications, Research and Development, Sales and Marketing Pan, burchell, ohare, reiss
Creative agency PAN has strengthened its senior team with the arrival of Jan Reiss as associate director and the promotion …
NHS ‘behind the curve’, warns government
October 10, 2013Medical Communications, Sales and Marketing NHS, curve, technology
The government is on track to deliver a paperless NHS by 2018, according to parliamentary undersecretary of state for health …
Sanofi appoints senior vice president
October 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, warnery
Vincent Warnery has been appointed as the senior vice president to Sanofi’s new Global Consumer Healthcare Division. He will remain …
Lilly staff ‘divulged secrets’
October 10, 2013Medical Communications, Sales and Marketing China, bribery, lilly
Two former staff from Eli Lilly & Company have been accused in a US court of passing on industrial secrets …
Life makes senior changes
October 10, 2013Medical Communications Life Healthcare
Marketing comms agency Life has restructured as several senior personnel change their positions and titles. Reg Manser is leaving his …
Janssen takes on GSK hep C drug
October 9, 2013Research and Development, Sales and Marketing GSK, GSK2336805, HCV, Janssen
Janssen Pharmaceuticals has acquired one of GlaxoSmithKline’s investigational hepatitis C treatments and will look at it in combination with various …
SMC must be ‘more flexible’ – health minister
October 9, 2013Sales and Marketing CDF, NICE, SMC
The Scottish health secretary Alex Neil has announced a series of fundamental changes to improve access to new medicines in …
Bayer pill gains FDA approval despite shutdown
October 9, 2013Sales and Marketing Bayer, FDA, adempas, hypertension
In the midst of the US shutdown of government agencies the FDA has managed to approve Bayer’s Adempas for patients …
Three hires for RSA
October 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interim, life sciences, rsa
Life sciences executive search and interim management firm RSA has made three appointments to its European team. Elmar Scheuba has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
